A detailed history of Pictet & Cie (Europe) Sa transactions in Abb Vie Inc. stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 206,571 shares of ABBV stock, worth $41.4 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
206,571
Previous 196,581 5.08%
Holding current value
$41.4 Million
Previous $33.7 Million 20.99%
% of portfolio
0.97%
Previous 0.83%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$163.84 - $199.33 $1.64 Million - $1.99 Million
9,990 Added 5.08%
206,571 $40.8 Million
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $1.62 Million - $1.89 Million
10,476 Added 5.63%
196,581 $33.7 Million
Q1 2024

May 07, 2024

BUY
$159.82 - $182.1 $7.37 Million - $8.4 Million
46,143 Added 32.97%
186,105 $33.9 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $605,440 - $681,868
4,400 Added 3.25%
139,962 $21.7 Million
Q3 2023

Nov 02, 2023

BUY
$133.59 - $154.65 $6.28 Million - $7.27 Million
47,019 Added 53.1%
135,562 $20.2 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $254,286 - $316,443
1,919 Added 2.22%
88,543 $11.9 Million
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $133,619 - $153,882
-924 Reduced 1.06%
86,624 $13.8 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $10.3 Million - $12.4 Million
74,738 Added 583.43%
87,548 $0
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $1.3 Million - $1.49 Million
9,660 Added 306.67%
12,810 $1.72 Billion
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $11,009 - $13,996
-80 Reduced 2.48%
3,150 $482,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $330,429 - $363,762
3,230 New
3,230 $350,000
Q1 2019

May 01, 2019

SELL
$77.14 - $90.79 $301,694 - $355,079
-3,911 Closed
0 $0
Q4 2018

Jan 31, 2019

SELL
$77.85 - $96.01 $115,996 - $143,054
-1,490 Reduced 27.59%
3,911 $361,000
Q3 2018

Nov 07, 2018

BUY
$88.91 - $98.84 $17,337 - $19,273
195 Added 3.75%
5,401 $511,000
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $17,507 - $20,714
195 Added 3.89%
5,206 $482,000
Q1 2018

May 09, 2018

SELL
$92.01 - $123.21 $460 - $616
-5 Reduced 0.1%
5,011 $474,000
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $934,827 - $1.03 Million
-10,438 Reduced 67.54%
5,016 $485,000
Q2 2017

Aug 09, 2017

BUY
N/A
15,454
15,454 $1.12 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pictet & Cie (Europe) Sa Portfolio

Follow Pictet & Cie (Europe) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.